209
Participants
Start Date
January 1, 2017
Primary Completion Date
March 1, 2024
Study Completion Date
April 1, 2024
Immunotherapy
Received neoadjuvant chemotherapy plus immunotherapy
Sun Yat-sen University Cancer Center, Guangzhou
Jiangmen Central Hospital
OTHER
Henan Cancer Hospital
OTHER_GOV
Sun Yat-sen University
OTHER